Citation Tools

Download PDFPDF
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)

Download to a citation manager

Cite this article as:
Alberts DS, Liu PY, Wilczynski SP, et al
Phase II trial of imatinib mesylate in recurrent, biomarker positive, ovarian cancer (Southwest Oncology Group Protocol S0211)